# Assessment of Blood Glucose Monitoring Devices With New Insight Features

> **NCT02929654** · NA · COMPLETED · sponsor: **LifeScan** · enrollment: 267 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** OneTouch Verio®
- **DEVICE:** OneTouch Verio® Flex
- **DEVICE:** Subject's Own Blood Glucose Meter

## Key facts

- **NCT ID:** NCT02929654
- **Lead sponsor:** LifeScan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2017-06-22
- **Final completion:** 2017-06-22
- **Target enrollment:** 267 (ESTIMATED)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929654, "Assessment of Blood Glucose Monitoring Devices With New Insight Features". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02929654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*